These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15655386)

  • 21. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin-angiotensin system in the brain as a new target of antihypertensive therapy.
    Ito S; Komatsu K; Yajima Y; Hirayama A
    Hypertens Res; 2008 Aug; 31(8):1487-8. PubMed ID: 18971519
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective Ang II (AT1) receptor blockade: a rational approach to end-organ protection in hypertension.
    Burnier M
    Int J Clin Pract Suppl; 2000 Aug; (111):9-13. PubMed ID: 15977401
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT.
    Laragh JH; Sealey JE
    Am J Hypertens; 2003 May; 16(5 Pt 1):407-15. PubMed ID: 12745204
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypertension in ethnic groups: epidemiological and clinical perspectives.
    Dwivedi G; Beevers DG
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):955-63. PubMed ID: 19673673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
    Weber MA; Giles TD
    Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editor's Note. The Renin-Angiotensin System: Today and Tomorrow in Research and Clinical Practice.
    Alderman MH
    Am J Hypertens; 2011 Nov; 24(11):1157. PubMed ID: 22008965
    [No Abstract]   [Full Text] [Related]  

  • 33. Aliskiren: the first renin inhibitor for clinical treatment.
    Jensen C; Herold P; Brunner HR
    Nat Rev Drug Discov; 2008 May; 7(5):399-410. PubMed ID: 18340340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypertensiology 2007].
    Middeke M
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1368-70. PubMed ID: 17570082
    [No Abstract]   [Full Text] [Related]  

  • 35. Managing cardiovascular and renal risk: the potential of direct renin inhibition.
    Sever PS; Gradman AH; Azizi M
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):65-76. PubMed ID: 19502253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements.
    Rydén L; Waeber B; Ruilope LM; Mancia G; Volpe M; Holzgreve H; Mogensen CE; Laurent S
    Blood Press; 2008; 17(5-6):250-9. PubMed ID: 19012063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypertension combination therapy with renin-angiotensin system blockers].
    Soucek M
    Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
    Weir MR
    Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):416-21. PubMed ID: 17693755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current neurohumoral and therapeutic aspects of hypertension].
    Malaia LT; Lapshina LA
    Vestn Akad Med Nauk SSSR; 1981; (9):22-32. PubMed ID: 6913349
    [No Abstract]   [Full Text] [Related]  

  • 40. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
    Hollenberg NK
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.